Skip to main content

Prostate cancer: cause of metastasis discovered

Advertisement

In the majority of cases, prostate cancer remains localised and is therefore easily treatable. However, around 20 per cent of patients develop metastatic, incurable prostate cancer, which claims approximately 5,000 lives every year in Austria alone. Until now, there has been no satisfactory explanation as to why some patients develop metastases whilst others do not. A research team at MedUni Vienna has now discovered the significant changes in a protein that drive the growth and spread of prostate tumours. In their study, the researchers broke new ground by investigating the role of the protein KMT2C in prostate cancer. This protein acts as a regulator of key processes within the cells. If KMT2C loses this regulatory capacity due to mutations, the proliferation of the MYC oncogene is stimulated. This, in turn, drives cells to grow and spread the tumour at an increased rate. “Our study offers new insights into the previously poorly understood transition from locally confined to lethal, metastatic prostate cancer,” says study leader Lukas Kenner, highlighting the research findings. The new findings could also provide fresh impetus for the diagnosis and treatment of prostate cancer. For instance, the KMT2C mutation status could be determined via a blood test, thereby enabling early diagnosis and treatment. With the help of new drugs (MYC inhibitors), the increased cell division and associated metastasis could also be prevented. Furthermore: “As a high KMT2C mutation is characteristic of many types of cancer, such as breast, lung, bowel, bladder and even skin cancer, our study results have great potential for the research, diagnosis and treatment of malignant tumours in general,” says Kenner. Reference: MedUni Vienna, VetMedUni Vienna. KMT2C Methyltransferase Domain-regulated 1 INK4A expression suppresses prostate cancer metastasis, Molecular Cancer 2022; https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-022-01542-8

#prostatecancer #carcinoma #oncology #oncogene #metastasis #urology #cancertherapy #medicine #medimpressions

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate